Table 1.
Baseline characteristics of patients with and without stroke
| Stroke Cases | Non-Stroke Controls | ||
|---|---|---|---|
| Demographics | (N=71) | (N=3114) | p-value |
| Age, mean ± SD | 69.0 ± 11.0 | 67.6 ± 10.3 | 0.32 |
| Male, n(%) | 70 (98.6) | 3068 (98.5) | 1.00 |
| Prior MI, n(%) | 6 (8) | 418 (13) | 0.29 |
| Hypertension, n(%) | 54 (76) | 2196 (71) | 0.36 |
| Heart Failure, n(%) | 45 (63) | 2154 (69) | 0.30 |
| Diabetes Mellitus Type 2, n(%) | 33 (46) | 1252 (40) | 0.33 |
| Peripheral Artery Disease, n(%) | 12 (17) | 293 (9) | 0.04 |
| Coronary Artery Disease, n(%) | 51 (72) | 2156 (69) | 0.70 |
| Charlson Comorbidity Index, mean ± SD | 2.7 ± 2.0 | 2.7 ± 1.8 | 0.98 |
| Selim Comorbidity Score, mean± SD | 4.9 ± 3.0 | 5.2 ± 2.9 | 0.51 |
| CHA2DS2-VASc Score, mean ± SD | 3.5 ± 1.9 | 3.2 ± 1.6 | 0.24 |
| CHA2DS2-VASc Score by Group | |||
| 0, n(%) | 4 (5.6) | 240 (7.7) | |
| 1, n(%) | 9 (12.7) | 285 (9.2) | |
| 2, n(%) | 9 (12.7) | 444 (14.3) | |
| 3, n(%) | 10 (14.1) | 710 (22.8) | |
| 4, n(%) | 20 (28.1) | 815 (26.2) | |
| 5, n(%) | 8 (11.3) | 424 (13.6) | |
| 6, n(%) | 6 (8.5) | 132 (4.2) | |
| 7, n(%) | 5 (7.0) | 63 (2.0) | |
| 8, n(%) | 0 (0) | 1 (0.03) | |
| 9, n(%) | 0 (0) | 0 (0) |